Cipla

News

Cipla launches COVID-19 drug remdesivir in India as disease ...

Efforts to get Gilead’s experimental COVID-19 drug remdesivir to patients in badly-hit India are building after drug maker Cipla announced it had launched the drug in the country.

News

Sanofi to combat shortages with European medicines ingredien...

Sanofi is to create a European company focused on production and marketing of active pharmaceutical ingredients (API) – the essential building blocks of medicines that are causing concerns

News

Cipla taps Wellthy for digital therapeutics expertise

Indian pharma company Cipla has made another play in the digital medicine category by taking a near-12% stake in start-up Wellthy Therapeutics.

Cipla launches COVID-19 drug remdesivir in India as disease ...

Sanofi to combat shortages with European medicines ingredien...

Cipla taps Wellthy for digital therapeutics expertise

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks